(Q39971035)

16 September 2017

0 references

Relapse rates with long-term antidepressant drug therapy: a meta-analysis (English)

1 reference

16 September 2017

0 references

Nolan Williams

1

1 reference

16 September 2017

Annie N Simpson

series ordinal

2

1 reference

16 September 2017

Kit Simpson

series ordinal

3

1 reference

16 September 2017

Ziad Nahas

series ordinal

4

1 reference

16 September 2017

1 July 2009

1 reference

16 September 2017

Human Psychopharmacology

1 reference

16 September 2017

24

1 reference

16 September 2017

5

1 reference

16 September 2017

401-408

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

16 September 2017

1 reference

Three-year outcomes for maintenance therapies in recurrent depression

21 January 2018

1 reference

7 January 2021

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

1 reference

7 January 2021

Fluoxetine in the prevention of depressive recurrences: a double-blind study.

1 reference

7 January 2021

Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy

1 reference

7 January 2021

Maintenance Phase Efficacy of Sertraline for Chronic Depression A Randomized Controlled Trial

1 reference

7 January 2021

Placebo Response and Antidepressant Clinical Trial Outcome

1 reference

7 January 2021

Basic concepts in meta-analysis: A primer for clinicians.

1 reference

7 January 2021

Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy

1 reference

7 January 2021

Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.

1 reference

7 January 2021

Summing up evidence: one answer is not always enough.

1 reference

7 January 2021

A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder

1 reference

7 January 2021

Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.

1 reference

7 January 2021

Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.

1 reference

7 January 2021

Predictors of relapse in a prospective study of fluoxetine treatment of major depression.

1 reference

7 January 2021

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

7 January 2021

Antidepressant dose reduction and the risk of relapse in major depressive disorder

1 reference

7 January 2021

Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study

1 reference

7 January 2021

Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

1 reference

7 January 2021

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

1 reference

7 January 2021

Multiple recurrences of major depressive disorder.

1 reference

7 January 2021

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

7 January 2021

How should meta-regression analyses be undertaken and interpreted?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1033

1 reference

16 September 2017

1 reference